Page Comparison

Anchor
RecommendCVXorGroupLevel RecommendCVXorGroupLevel

Rules for Recommending at the CVX Code vs. Vaccine Group Level 

• When recommending in the Pfizer COVID-19 2-dose Series, recommend CVX 208 for the next target dose.
• When recommending in the Moderna COVID-19 2-dose Series, recommend CVX 207 for the next target dose.
• When recommending in the Janssen COVID-19 1-dose Series, recommend CVX 212 for the next target dose. 
• If patient has no shots on record, 
  • and is > = 12 years old, recommend at the vaccine group level at today's date. 
  • and is < 12 years old, recommend at the vaccine group level at 12 years old.

Series Completion Special Rule

• Once a patient completes:
  • either the Pfizer COVID-19 2-dose series or the Moderna COVID-19 2-dose series, the Recommendation is Conditional and the reason code is COMPLETE_HIGH_RISK. 
  • either the Pfizer COVID-19 2-dose series or the Moderna COVID-19 2-dose series AND receives an additional dose¹, the Recommendation is Not Recommended and the reason code is COMPLETE.
  • either the 1) Janssen COVID-19 1-dose series, 2) COVID-19 vaccine series not authorized by the FDA, but authorized by the WHO, or a 3) COVID-19 vaccine series not authorized by the FDA or WHO, but is an active COVID-19 vaccine candidate as part of a U.S.-based clinical trial of a COVID-19 vaccine, the Recommendation is Not Recommended/ COMPLETE_HIGH_RISK.

• • with CVX 208 as Dose 1 and Dose 2,
    • and is >= 65 years old, recommend a booster dose of Pfizer (CVX 208) at Dose 2 + recommended interval (6 months), along with recommendation reason code SUPPLEMENTAL_TEXT; Descriptive Text: "Although patients are considered fully vaccinated two weeks after their second dose of the Pfizer COVID-19 vaccine, a booster dose is recommended 6 months after the second dose for patients >= 65 years old."
    • and is >= 18 years and < 65 years old, the recommendation is Conditional and the reason code is COMPLETE_HIGH_RISK.
    • and is < 18 years old, the recommendation is Conditional/ COMPLETE_HIGH_RISK.
    • and receives an additional dose¹ or booster dose², the Recommendation is Not Recommended and the reason code is COMPLETE.
  • the Pfizer COVID-19 2-dose series where not all doses administered were CVX 208 or the Moderna COVID-19 2-dose series, 
    • the Recommendation is Conditional and the reason code is COMPLETE_HIGH_RISK.
    • and receives an additional dose¹, the Recommendation is Not Recommended and the reason code is COMPLETE.
  • either the 1) Janssen COVID-19 1-dose series, 2) COVID-19 vaccine series not authorized by the FDA, but authorized by the WHO, or a 3) COVID-19 vaccine series not authorized by the FDA or WHO, but is an active COVID-19 vaccine candidate as part of a U.S.-based clinical trial of a COVID-19 vaccine, the Recommendation is Not Recommended/ COMPLETE_HIGH_RISK.

Rules for an Additional Dose¹

• If a patient completes a COVID-19 vaccine series via the Pfizer 2-dose series or Moderna 2-dose series and receives an additional shot of CVX 208, CVX 207, or CVX 213:
  • at < 28 days - 4 days after series completion, then evaluate the shot as Valid/ SUPPLEMENTAL_TEXT; Descriptive Text: "The timing of the administration of this shot does not follow the guidelines regarding the minimum age and/or minimum interval."
  • at >= 28 days - 4 days after series completion, then evaluate the shot as Valid.
• If a patient receives a subsequent shot(s) after they have received an additional dose¹, then evaluate that shot(s) as Accepted/ EXTRA_DOSE. 

Rules for Booster Dose²

• If a patient completes a COVID-19 vaccine series via the Pfizer 2-dose series

• (with CVX 208 only) and a booster dose² of CVX 208, 
  • at < 28 days - 4

• • days after series completion, then evaluate the shot as Valid/ SUPPLEMENTAL_TEXT; Descriptive Text: "The timing of the administration of this shot does not follow the guidelines regarding the minimum age and/or minimum interval."
  • at >= 28 days - 4

• • days after series completion, then evaluate the shot as Valid.
• If a patient receives

• an additional shot(s) after they have received

• a booster dose

• ², then evaluate

• those shots as Accepted/ EXTRA_DOSE.